Johnson & Johnson, Pharmaceutical Research & Development
Raritan, NJ and PharmaMar USA, Cambridge, MA
Yondelis is a new anti-tumour drug derived from the marine organism, Ecteinascidia turbinata, a 'sea squirt', or tunicate, found in the Caribbean and Mediterranean seas.
It is a naturally occurring compound in that it is produced by a living marine organism. Yondelis (ET-743) has been extracted from naturally growing and farmed Ecteinascidia turbinata, and a hemisynthetic process has been developed so that the drug may be manufactured chemically.
It is commonly agreed that ET-743 binds to the minor groove of the DNA and inhibits cell proliferation, leading to p53-independent apoptosis of cancer cells.
It was developed by a Spanish company called PharmaMar that specializes in anti-tumor drugs from marine sources.
More at http://www.pharmamar.es
Ann's NOTE: This information came to us as a result of a woman on the trial who posted to the BC METS list. She was telling the others that she has had good results with this product.
LINK to maker of this
|Remember we are NOT Doctors and have NO medical training.|
This site is like an Encyclopedia - there are many pages, many links on many topics.
Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.